Tandem Diabetes Care, Inc. Aktie News
14,05 €
5,03 %
L&S, 25. September, 22:54 Uhr.
Geschlossen.
Index
Industrie
tracken
Tandem Diabetes Care, Inc. Aktie News
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) (das Unternehmen), ein globales Unternehmen für Insulinabgabe und Diabetes-Technologie, berichtete heute über seine Finanzergebnisse für das am 30. Juni 2026 beendete Quartal. Finanzielle Highlights des zweiten Quartals 2026: Weltweite Verkäufe von 254,6 Mio. USD, darunter 179,3 Mio. USD in den Vereinigten Staaten (U.S.). Bru...
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--Die t:slim X2™-Insulinpumpe von Tandem Diabetes Care ist jetzt in fünf EU‑Ländern mit dem FreeStyle Libre 3 Plus-CGM-Sensor von Abbott kompatibel.
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TandemMobi--Tandem Diabetes Care receives CE mark for AID systems in Europe to include use in type 1 diabetes during pregnancy and adults with type 2 diabetes.
Tandem Diabetes Care NASDAQ: TNDM reported record first-quarter pump shipments and sales for 2026, while reaffirming its full-year outlook as the diabetes technology company advances a shift toward pharmacy-channel reimbursement, expands direct international operations and prepares several product launches.
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2026 and reaffirmed financial guidance for the year ending December 31, 2026. First Quarter 2026 Financial and Strategic Highlights Achieved record first quarter pump shipments, sales and gross marg...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026 at 5:20 pm Eastern Time (2:20 pm Pacific Time), and Goldman Sachs 47th Annual Global Healthcare ...
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--FDA clears Tandem Diabetes Care's Control-IQ+ automated insulin delivery technology for use in pregnancy for people with type 1 diabetes.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
